Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Cancer?02:12

What is Cancer?

11.1K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
11.1K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.5K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancer02:18

Cancer

49.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human TET2-Mutant Clonal Hematopoiesis Expansion Is Driven by Distinct Inflammatory Signaling Responses in Stem Cells Versus Myeloid Progeny.

Blood cancer discovery·2025
Same author

Old Habits Die Hard: DNA Methylation Patterns Persist in Experimental Transdifferentiation.

Cellular reprogramming·2025
Same author

H4K20me3-Mediated Repression of Inflammatory Genes Is a Characteristic and Targetable Vulnerability of Persister Cancer Cells.

Cancer research·2024
Same author

Vitamin C activates young LINE-1 elements in mouse embryonic stem cells via H3K9me3 demethylation.

Epigenetics & chromatin·2023
Same author

CRISPR/dCas9 DNA methylation editing is heritable during human hematopoiesis and shapes immune progeny.

Proceedings of the National Academy of Sciences of the United States of America·2023
Same author

Identification of mammalian transcription factors that bind to inaccessible chromatin.

Nucleic acids research·2023

Related Experiment Video

Updated: Sep 5, 2025

In Vitro Evaluation of Oncogenic Transformation in Human Mammary Epithelial Cells
09:44

In Vitro Evaluation of Oncogenic Transformation in Human Mammary Epithelial Cells

Published on: September 24, 2020

4.7K

Corrupted devolution: How normal cells are reborn as cancer precursors.

Alice Lord1, Gabriella Ficz1

  • 1Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, EC1M 6BQ London, UK.

The International Journal of Biochemistry & Cell Biology
|July 7, 2022
PubMed
Summary

Cancer development involves epigenetic changes similar to early development. Targeting these reactivated embryonic programs offers new strategies for cancer prevention and treatment.

Keywords:
DedifferentiationEmbryogenesisEpigeneticsTransformation

More Related Videos

Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells
08:33

Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells

Published on: April 25, 2014

20.0K
Cell Population Analyses During Skin Carcinogenesis
06:53

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

12.6K

Related Experiment Videos

Last Updated: Sep 5, 2025

In Vitro Evaluation of Oncogenic Transformation in Human Mammary Epithelial Cells
09:44

In Vitro Evaluation of Oncogenic Transformation in Human Mammary Epithelial Cells

Published on: September 24, 2020

4.7K
Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells
08:33

Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells

Published on: April 25, 2014

20.0K
Cell Population Analyses During Skin Carcinogenesis
06:53

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

12.6K

Area of Science:

  • Epigenetics
  • Developmental Biology
  • Cancer Biology

Background:

  • Cancers exhibit similar epigenetic deregulation patterns, including DNA hypomethylation and promoter CpG island hypermethylation.
  • These cancer epigenomes resemble patterns seen in early development, suggesting reactivation of embryonic programs is crucial for cancer initiation.

Purpose of the Study:

  • To propose a model where two waves of dedifferentiation drive cancer development.
  • To explore the therapeutic implications of targeting reactivated embryonic programs and pluripotency networks for cancer prevention.

Main Methods:

  • Comparative analysis of cancer epigenomes and early developmental programs.
  • Hypothesizing cellular transitions based on epigenetic reprogramming.

Main Results:

  • Cancer initiation and malignancy progression may involve two distinct waves of cellular dedifferentiation.
  • Reactivation of embryonic programs and pluripotency networks in healthy tissues could identify pre-cancerous cells.

Conclusions:

  • Targeting epigenetic gatekeepers and peri-implantation cellular identities could revolutionize cancer diagnosis and prevention.
  • These findings have potential applications across various cancer types, including solid and hematological malignancies.